AZ buy out and Tax saving?

Discussion in 'Pfizer' started by Anonymous, Apr 28, 2014 at 9:03 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Anyone knows the savings we'll make by escaping US to relocate tax in UK? Barack must be grey, too bad for him and his communist fiends !!!
     

  2. Anonymous

    Anonymous Guest

    There will be huge savings of course. Not only will we not pay taxes while putting money back to work for Pfizer. repat. tax at 35%, we'll pay a 35% premium to Jan AZ stock price. Price not so high when looked at in this light.

    The big question is: what will the effective tax rate be when we convince the UK to lower our tax rate if we move Pfizer's domicile to the UK vs the US. This is a classic example of leverage. The US will watch Pfizer move oversees, the UK will work with Pfizer to make it easier to move.

    I believe we'll pay too much for AZ. Their pipeline is potentially good, but they're losing some big drugs. Only way to make this profitable is to cut costs significantly, nail drug launches and squeeze every dime from existing products. Historically we haven't been able to have success on all three.
     
  3. Anonymous

    Anonymous Guest

    Obama must either be a communist or the dumbest president of the USA ever.
     
  4. Anonymous

    Anonymous Guest

    Ian wants to go home to family in U.K.
     
  5. Anonymous

    Anonymous Guest

    how about both....
     
  6. Anonymous

    Anonymous Guest

    Cost savings? Look at the tax bill alone. The value if AZ is not just the cash flow of products, but AZ offers a uk home country that allows Pfizer to keep more earnings for reinvestment and if dividends to shareholders. Now watch Barry cry and call it selfish. Great move for Pfizer. Then Ian will split it up with stronger separate companies. Genius.
     
  7. Anonymous

    Anonymous Guest

    Pfizer will pay a 20% tax rate in the UK if they acquire AZ. They will pay 0% on earnings already taxed in other countries. Smaller bio techs are already doing this. Pfizer will be the first big pharma company to do this. I'm sure many more will follow. Ian seems to be ahead of game. It's a no brainier from a business standpoint. The US better wise up, or you are going to see many more companies do this when opportunities arise. When you are taxed to much and government becomes antagonistic towards business, business's have to find ways to compete. Big loser in the long run, the US a Treasury. They only have themselves to blame.
     
  8. Anonymous

    Anonymous Guest

    Probably the only message making sense on the board these days, except on one point... Our tax policy is killing us and making companies like ours flee elsewhere. But the spend will not go down..so just add it up: WE, WE will pay the bill ourselves to the US Treasury. WE are the onese stuffed, as usual, someone has to pay for the Ocare and the rest....
     
  9. Anonymous

    Anonymous Guest

    Hey Pfizer: Take your money and shove it where the sun don't shine! We don't need or want you!!!!!
     
  10. Anonymous

    Anonymous Guest

    Ummmmm that would be both.
     
  11. Anonymous

    Anonymous Guest

    this is exactly what Obomba wants.....chase out biz, no more jobs, gov't in control because poor people are beholden. Sound like Soviet, N. Korea or Cuba? You're correct. It's called Communism and that's what Obomba is.....a socialist who wants to take the U.S. down. He's just been doing it slowly and methodically so the undereducated don't see it happening. It's sad actually, but very true.
     
  12. Anonymous

    Anonymous Guest

    If buying AZ for the oncology assets, Ian would be well-advised to clean house on the Pfizer side - GN and crew will only piss away the AZ oncology pipeline as they did with the Wyeth one.
     
  13. Anonymous

    Anonymous Guest

    Pfizer's biggest single customer is the US government. Go ahead and minimize your US tax payment. Go ahead and move US R&D jobs to UK to appease the Brits. Go head, make our day.
     
  14. Anonymous

    Anonymous Guest

    both
     
  15. Anonymous

    Anonymous Guest

    This is the letter to the UK Prime Minister

    Rt Hon David Cameron MP
    10 Downing Street
    London
    SW1A 2AA
    Dear Prime Minister,
    I am writing to you to address the concerns of the UK Government and science community and your desire to have firm and enduring assurances from us about our commitment to the UK and its life sciences agenda.
    We would like to confirm that today, Pfizer made a non-binding cash and share proposal valuing each AstraZeneca share at £50 to the Board of AstraZeneca, as detailed in our accompanying public statement. We believe the industrial logic for a combination between Pfizer and AstraZeneca is compelling. A combined company would bring together powerful and world leading research expertise in key therapeutic areas such as Oncology, Inflammation, and Cardiovascular and Metabolic Disorders, in which the world class academic research resources in the “golden triangle” of Oxford, Cambridge and London would represent a vital component, along with the positive environment for inward investment that the UK Government has created. Ultimately, establishing the world’s largest research-based pharmaceutical company in the UK, together with the commitments made in this letter represent a strong indicator of the incentives that your Government has created to attract successful business to the UK.
    We recognize that our approach may create uncertainty for the UK Government and scientific community given the strategic importance of life sciences to the Government’s Industrial Strategy and the significance of the transaction. We would therefore like to assure the Government of our long term commitment to the UK where Pfizer already employs a significant number of colleagues across Research, Commercial, and Administrative roles. To that end, therefore, subject to successful completion of our combination with AstraZeneca on the basis proposed by us, we will make the following series of significant and tangible commitments:
    Pfizer commits to establishing the combined company’s corporate and tax residence in England.
    Pfizer commits to complete the construction of the currently planned AstraZeneca Cambridge campus, creating a substantial R&D innovation hub in Cambridge and the wider scientific community, which will include core research units, laboratory based scientific support lines and European clinical development and regulatory functions.
    Pfizer will base key scientific leadership in the UK who will lead all European and certain global R&D functions based in Cambridge.
    Pfizer commits to integrate the operations of the combined company so as to employ a minimum of 20% of the combined company’s total R&D workforce in the UK going forward.
    Pfizer will actively look to locate manufacturing operations of the combined company in the UK, subject to the timing of the UK Patent Box proposals, and will retain substantial commercial manufacturing facilities in Macclesfield.
    Pfizer commits to base the combined company’s European business HQ in the UK.
    Pfizer commits to base the combined company’s EU Regulatory HQ in the UK.
    Pfizer commits to invite at least two AstraZeneca Board Members to join the Board of the new company.
    Pfizer commits to hold, as appropriate, Board Meetings in the UK and participate meaningfully in the UK commercial, economic and social community.

    Clearly, predictability and stability in the local and global commercial environment, as well as the UK Government’s efforts to maintain incentives for investment, are important factors to enable success. We make these commitments for a minimum of five years, recognizing our ability, consistent with our fiduciary duties, to adjust these obligations should circumstances significantly change. Our Board has endorsed these commitments in a formal Pfizer Board resolution and will publish a statement describing these promises to the British public. In reflection of the binding nature of these commitments, we are including this letter in our public announcement issued pursuant to the UK Takeover Code regarding the possible combination.
    As mentioned above, we view our partnership with the UK Government as a critical part of this potential transaction. We look forward to continued discussions with you.
    Yours sincerely,
    Ian C. Read
     
  16. Anonymous

    Anonymous Guest

    Pfizer will move a significant number of R&D positions to the UK to make this deal go.

    Keep on taxing yourselves to death America, so we can have better educated unemployed sheeple.
     
  17. Anonymous

    Anonymous Guest

    Only little people pay taxes. There's no reason at all why the rich and big corporations should pay any.
     
  18. Anonymous

    Anonymous Guest

    Be happy: this will cost about $100 to every single one of us in the US. Am really happy to pay this instead of PFE. I do.
     
  19. Anonymous

    Anonymous Guest

    supply side - trickle down economics is good for the little people, right?
     
  20. Anonymous

    Anonymous Guest

    go craw back under your libtard rock, get a life and stop responding to your own posts